Alan Meds vs Green Cap Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Green Cap Health
Best for **Texas residents only** who want a vertically integrated provider + pharmacy (Green Cap IS the compounding pharmacy, not a marketplace platform working with a separate 503A partner) with aggressive $79/mo first-month pricing on compounded semaglutide. Strong fit for Texas buyers who value single-entity supply-chain accountability over the standard DTC marketplace abstraction. Not applicable for tirzepatide seekers (semaglutide only).Starting at $79/mo
Side-by-Side Comparison
| Feature | Alan Meds | Green Cap Health |
|---|---|---|
| Overall Score | ✓7.7/10 | 6.5/10 |
| Starting Price | $99/mo | ✓$79/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.3 ★ /5 |
| Features | 5 features | ✓9 features |
| States Available | ✓46 | 1 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Green Cap Health
Pros
- ✓**Vertically integrated provider + pharmacy model is genuinely rare** — Green Cap operates as both the clinical practice AND the dispensing 503A Texas compounding pharmacy under one entity. Removes the typical DTC marketplace + separate-503A-partner abstraction. Clearest supply-chain accountability in any single-state provider in the directory.
- ✓Aggressive $79/mo first-month intro pricing — competitive with the broader DTC market despite being Texas-only
- ✓Multi-vertical positioning lets Texas patients consolidate GLP-1 + hair + skin + sexual wellness under one telehealth practice
- ✓Phone support published with Houston TX area code (832) 648-2801
- ✓Same-day provider review framing reduces friction vs 24-48hr competitors
- ✓Verbatim positioning ('not a supplement brand... real providers and a real pharmacy') is honest brand-differentiation framing
Cons
- ✗**Texas only** — single-state operation excludes 49 states + DC. Buyers outside Texas cannot use this platform.
- ✗**Tirzepatide NOT offered** — semaglutide only. Patients seeking the higher-magnitude tirzepatide option (Wegovy vs Zepbound = ~14.9% vs ~20.9% TBWL per STEP-1 vs SURMOUNT-1) need to look elsewhere.
- ✗LegitScript certification status NOT disclosed
- ✗Named medical director / clinical leadership NOT disclosed (only 'doctors, nurse practitioners, and pharmacists' generic)
- ✗Verbatim FDA compounded-medication disclaimer NOT visible on homepage
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed
- ✗503A pharmacy designation is implied by 'compounding pharmacy' framing but NOT explicitly stated; 503B not mentioned
- ✗Governing law / arbitration venue / corporate physical address NOT disclosed
- ✗Refund / cancellation policy NOT publicly detailed
- ✗$79 is FIRST-MONTH intro — refill / standard pricing not disclosed on homepage; common DTC pattern is step-up at refill
Our Verdict
Alan Meds edges out Green Cap Health with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Green Cap Health remains a solid alternative, especially if you're looking for **Texas residents only** who want a vertically integrated provider + pharmacy (Green Cap IS the compounding pharmacy, not a marketplace platform working with a separate 503A partner) with aggressive $79/mo first-month pricing on compounded semaglutide. Strong fit for Texas buyers who value single-entity supply-chain accountability over the standard DTC marketplace abstraction. Not applicable for tirzepatide seekers (semaglutide only)..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.